Baker Bros. Advisors LP Kymera Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 5,995,929 shares of KYMR stock, worth $281 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
5,995,929
Previous 5,995,929
-0.0%
Holding current value
$281 Million
Previous $241 Million
31.97%
% of portfolio
1.96%
Previous 2.67%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$314 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$303 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$281 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$245 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$242 Million6.21% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.56B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...